![]() |
![]() |
![]() |
![]() |
P-012 | IMPLEMENTATION OF INFORMATION TECHNOLOGY GOVERNANCE FRAMEWORK FOR BLOOD SERVICES IN RESOURCE CONSTRAINED SETTING | Tonderai Mapako | ![]() |
![]() |
|||
P-022 | IMPROVING NEONATAL AND PAEDIATRIC CLINICAL OUTCOMES THROUGH PATIENT BLOOD MANAGEMENT EDUCATION | David Peterson | ![]() |
![]() |
|||
P-024 | INCONGRUENCE IN WHOLE BLOOD DONOR SELECTION CRITERIA AS EVALUATED BY EXPERTS IN THE TRANSPOSE PROJECT IN COMPARISON WITH DIRECTIVE 2004/33/EC | Stefano Fontana | ![]() |
![]() |
|||
P-031 | PARTNERSHIP TO ELIMINATE BLOOD WASTE: THE CARDIAC SURGERY BLOOD COOLER INITIATIVE | Kerry OBrien | ![]() |
![]() |
|||
P-033 | INTERACTIVE METRICS FOR MONITORING BLOOD SUPPLY MANAGEMENT SYSTEM IN A LOW RESOURCE SETTING | Tonderai Mapako | ![]() |
![]() |
|||
P-036 | IDENTIFYING COMPATIBLE BLOOD FOR RH ALLOIMMUNIZED PATIENTS: AN INTERNATIONAL CASE | Margaret Keller | ![]() |
![]() |
|||
P-071 | CHARACTERISTICS OF WHOLE BLOOD AND APHERESIS DONORS IN THE RUSSIAN FEDERATION | Alexander Chechetkin | ![]() |
![]() |
|||
P-074 | FINNISH BLOOD DONOR BIOBANK | Jukka Partanen | ![]() |
![]() |
|||
P-080 | FAMILIAL HYPERCHOLESTEROLAEMIA SCREENING IN A BLOOD DONATION PROGRAM | stephen Eason | ![]() |
![]() |
|||
P-082 | FERRIDON - A NATIONAL CROSS-SECTIONAL STUDY ASSESSING THE PREVALENCE OF IRON DEFICIENCY USING FERRITIN ASSAY AMONG WHOLE-BLOOD DONORS IN FRANCE | Anne-Marie Fillet | ![]() |
![]() |
|||
P-091 | ZERO IS THE BEST RESULT: VALIDATION OF THE SKIN DISINFECTION METHOD | Saila Vasama | ![]() |
![]() |
|||
P-097 | INSIGHTS IN SAFETY AND RETENTION RATES OF DONOR VS COLLECTION VOLUME; RESULTS FROM AN INTERNATIONAL SURVEY OF PLASMAPHERESIS PRACTICES | Johanna Castrén | ![]() |
![]() |
|||
P-099 | COMPARISON OF PERFORMANCES OF SOFTWARE TRIMA ACCEL VERSION 6.06 TO VERSION 7 | André Rapaille | ![]() |
![]() |
|||
P-107 | DO DONERS OVER 66 YEARS OF AGE HAVE MORE ADVERCE EVENTS COMPARED TO OTHER AGE GROUPS | Tarja Jrvinen | ![]() |
![]() |
|||
P-110 | PROTECTION AGAINST POLLEN ALLERGY AND ASTHMA IN BLOOD DONORS BY PRESEASONAL ORAL SUPPLEMENTATION WITH AN IMMUNOMODULATORY AGARICUS BLAZEI-BASED MUSHROOM EXTRACT: A RANDOMIZED PLACEBO-CONTROLLED STUDY | Geir Hetland | ![]() |
![]() |
|||
P-125 | THE STORAGE MODE OF SHEEP PLATELET CONCENTRATES DIFFERENTIALLY AFFECTS MICROPARTICLE FORMATION | Gabriela Simonova | ![]() |
![]() |
|||
P-127 | DUAL POOLING STRATEGY FOR PRODUCTION OF PLATELET CONCENTRATES FROM 5 OR 6 BUFFY COATS | Nicolas Cellier | ![]() |
![]() |
|||
P-155 | ASSESSMENT OF RED CELL CONCENTRATES PRODUCED FROM 7 DAYS -STORED LEUCODEPLETED WHOLE BLOOD | Stephane Begue | ![]() |
![]() |
|||
P-156 | IGE SENSITIZATION PROFILES TO FOOD, INHALANT AND INSECT VENOM ALLERGENS IN NORWEGIAN BLOOD DONORS MEASURED WITH LINE-BLOT MULTIPLEX ENZYMOIMMUNOASSAY | Lise Sofie H Nissen-Meyer | ![]() |
![]() |
|||
P-159 | USE OF NANOPARTICLE TRACKING ANALYSIS TO CHARACTERISE MICROVESICLES IN RED CELL UNITS: EFFECTS OF STORAGE ON MICROVESICLE SIZE AND CONCENTRATION | John-Paul Tung | ![]() |
![]() |
|||
P-160 | MANUAL METHOD FOR WASHING RED BLOOD CELLS USING SAGM SOLUTION | Juha Eronen | ![]() |
![]() |
|||
P-195 | EVALUATION OF AN ANTIOXIDANT POWER MEASURE TO VALIDATE THE PLATELET CONCENTRATES VIRO-INACTIVATED BY INTERCEPT TREATMENT | Anas Lotens | ![]() |
![]() |
|||
P-196 | EVALUATION OF AN ANTIOXIDANT POWER MEASURE TO VALIDATE THE PLASMA UNITS VIRO-INACTIVATED BY METHYLEN-BLUE TREATMENT | Anas Lotens | ![]() |
![]() |
|||
P-201 | BIOTINYLATED RED BLOOD CELLS: A PROMISING APPROACH FOR MONITORING IN VIVO RED BLOOD CELL SURVIVAL IN CLINICAL TRIALS | Catherine RAVANAT | ![]() |
![]() |
|||
P-203 | INJECTABLE BIOTINYLATED PLATELETS FOR TRANSFUSION IN CLINICAL TRIALS | Catherine RAVANAT | ![]() |
![]() |
|||
P-209 | DOMESTIC AND INTERNATIONAL COLLABORATION FOR THE SCREENING AND PROCUREMENT OF RARE RED BLOOD CELLS | Sandra Nance | ![]() |
![]() |
|||
P-232 | PERFORMANCE EVALUATION OF ELECSYS SEROLOGY ASSAYS IN A BLOOD ESTABLISHMENT | Marie-Pierre RODENBACH | ![]() |
![]() |
|||
P-240 | INDUCTION HEATING: AN ADVANCED WASHING TECHNOLOGY TO PRESERVE SAMPLE INTEGRITY ON ALINITY S, ALINITY I, AND ARCHITECT I2000SR FOR TRANSFER TO NUCLEIC ACID TESTING INSTRUMENTS | Matt Effinger | ![]() |
![]() |
|||
P-277 | HIV PREVALENCE AND INCIDENCE ESTIMATES AMONG BLOOD DONORS IN FIVE REGIONS IN CHINA | Ling Shi | ![]() |
![]() |
|||
P-281 | SEPTIC PLATELET TRANSFUSION REACTIONS DUE TO ACINETOBACTER BAUMANNII AND STAPHYLOCOCCUS SAPROPHYTICUS DESPITE NEGATIVE PRIMARY TESTING AND NEGATIVE POINT-OF-RELEASE TESTING | David Peaper | ![]() |
![]() |
|||
P-313 | DISCREPANT LITTLE C TYPING IN AN RH:-26 DONOR | Tanya Cawthorne | ![]() |
![]() |
|||
P-320 | SIGNIFICANCE OF THE MONOCYTE MONOLAYER ASSAY IN PREDICTING THE CLINICAL RELEVANCE OF ANTI-GERBICH ANTIBODIES | Sofia Lejon Crottet | ![]() |
![]() |
|||
P-322 | DIFFERENCES IN STABILITY OF UNEXPECTED RED BLOOD CELL ANTIBODIES DETECTED AFTER REFRIGERATION OR FREEZING USING AUTOMATED ANALYZER IH-500 AND MANUAL TUBE METHODS | Jeong Won Shin | ![]() |
![]() |
|||
P-348 | RARE JENU NEGATIVE DONOR IDENTIFIED THROUGH INCOMPATIBLE CROSSMATCH | Tanya Powley | ![]() |
![]() |
|||
P-357 | MOLECULAR BLOOD GROUP SCREENING IN DONORS FROM ARABIAN COUNTRIES USING HIGH-THROUGHPUT MALDI-TOF SPECTROMETRY AND PCR-SSP | Brigitte Flesch | ![]() |
![]() |
|||
P-368 | A NOVEL ABOA GENE SINGLE NUCLEOTIDE MUTATION LEADS TO DISCREPANT RESULTS IN FORWARD/REVERSE AND MOLECULAR BLOOD GROUPING | Jana Rosochova | ![]() |
![]() |
|||
P-372 | A NOVEL RHD SPLICE DONOR SITE MUTATION LEADING TO A RHD-NEGATIVE PHENOTYPE | Jolanda Stettler | ![]() |
![]() |
|||
P-373 | CHARACTERIZATION OF TWO NOVEL RHD VARIANT ALLELES | Jolanda Stettler | ![]() |
![]() |
|||
P-376 | THE RHD ALLELE INVENTORY: LESSONS FROM HIGH-THROUGHPUT GENOME DATABASES | Franz WAGNER | ![]() |
![]() |
|||
P-380 | RHD ALLELIC VARIANTS IN CAUCASIAN DONORS SEROLOGICALLY CLASSIFIED AS D-NEGATIVE | Tommaso Mancuso | ![]() |
![]() |
|||
P-408 | COMPARISON OF ABO GENOTYPING METHODS: A STUDY OF TWO LOW RESOLUTION PCR ASSAYS IN A CLINICAL TESTING LABORATORY | margaret keller | ![]() |
![]() |
|||
P-423 | A RARE CASE OF SEVERE REFRACTORY THROMBOCYTOPENIA IN A PATIENT WITH COMBINED HLA CLASS I, HPA-1A AND HPA-3A ANTIBODIES IN HEMATOPOIETIC STEM CELL TRANSPLANTATION | Brigitte Flesch | ![]() |
![]() |
|||
P-426 | HUMAN NEUTROPHIL ANTIGEN ALLELE FREQUENCIES AND ASSESSMENT OF HNA ALLOIMMUNIZATION RISK IN BLOOD DONORS AND RECIPIENTS | Irina Krobinets | ![]() |
![]() |
|||
P-443 | CASE REPORT ANTI INDIAN B ANTIBODY IN A PREGNANT WOMAN OF INDIAN ORIGIN | Ann Lea Vogel | ![]() |
![]() |
|||
P-445 | SEVERE CASE OF HAEMOLYTIC DISEASE OF FETUS AND NEWBORN OCCURRING IN BABY WHO HAS INHERITED A NOVEL RHD ALLELE ASSOCIATED WITH A PARTIAL RHD POSITIVE PHENOTYPE | Tanya Powley | ![]() |
![]() |
|||
P-465 | HIGH -GRADE PARASITEMIA IN BABESIOSIS TREATED WITHOUT ADJUNCTIVE RED CELL EXCHANGE | Joseph Sweeney | ![]() |
![]() |
|||
P-492 | DEVELOPMENT OF A TRANSFUSION-INDICATION DATA-ENTRY PROGRAM AND ANALYSIS OF TRANSFUSION INDICATIONS THROUGH THIS PROGRAM IN A TERTIARY CARE HOSPITAL IN KOREA | Jeong Won Shin | ![]() |
![]() |
|||
P-514 | DEVELOPMENT OF AN OVINE MODEL OF HAEMORRHAGIC SHOCK | John-Paul Tung | ![]() |
![]() |
|||
P-518 | CHARACTERIZATION OF IMMUNOMODULATORY MEDIATORS IN CONVENTIONAL AND CRYOPRESERVED SHEEP PLATELET CONCENTRATES | Gabriela Simonova | ![]() |
![]() |
|||
P-519 | CHARACTERIZATION OF IMMUNOMODULATORY MEDIATORS IN SHEEP PACKED RED BLOOD CELLS: DEVELOPMENT OF A ROBUST TRANSFUSION MODEL | Gabriela Simonova | ![]() |
![]() |
|||
P-523 | TOWARDS UNDERSTANDING OF POST-TRANSFUSION IMMUNOMODULATION: SHEEP IMMUNE RESPONSES TO LIPOPOLYSACCHARIDE | Gabriela Simonova | ![]() |
![]() |
|||
P-536 | HAEMOGLOBIN OPTIMISATION USING IV IRON | Josephine McCullagh | ![]() |
![]() |
|||
P-547 | CD34 CALCULATION TOOL; A SIMPLE AND EASY TOOL FOR PERSONALIZED STEM CELL COLLECTION | Betina Sorensen | ![]() |
![]() |
|||
P-548 | IMMUNOTHERAPY PRODUCTS: BLOOD PRODUCT, PHARMACEUTICAL, OR A NEW CATEGORY ALL TOGETHER? | Sarah Vossoughi | ![]() |
![]() |
June 22-26, 2019 Basel
![]() |
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. ![]() To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress. ![]() |
![]() |
||
![]() |
|